An ischemic stroke occurs when a blockage occludes blood and oxygen flow to the brain. During an ischemic stroke, excessive free iron induces brain damage through oxidative stress and ferroptosis. Iron chelators such as Deferoxamine have been proposed as a potential treatment to help mitigate these negative effects by binding to and removing excessive iron. The purpose of this project is to analyze the effects of iron chelators on ischemic stroke models.